Form 4 for HHS HARTE HANKS INC
Accepted 2022-01-20 00:00:00 ET · period of report 2022-01-19 · accession 0001437749-22-001353 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-01-20 | 2022-01-19 | HHS | Linscott Brian | CEO, Dir | A - Grant | $7.37 | +9,623 | 308.2K | +3% | +$70.9K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-01-19 | A | A | 9,623 | $7.37 | 308,202 | D | — | — | (F1) On January 19, 2022, the reporting individual received 9,623 restricted stock unit (RSU) shares (18,745 RSU shares less 9,122 shares to cover tax withholdings) valued at $7.37 as part of his 2021 bonus package, paid in Q1 2022. |